Fluorescence-guided surgery enhances drug delivery understanding in cancer therapy, potentially boosting treatment efficacy.
This method utilizes optically labeled therapeutic antibodies to illuminate tumor margins during surgery.
Observational analysis of drug delivery mechanisms highlights challenges in current cancer therapies and their limitations.
This viewpoint emphasizes the need for further exploration of optical techniques to optimize therapeutic outcomes in oncology.
Abstract
This Viewpoint describes the use of optically labeled therapeutic antibodies in fluorescence-guided surgery to advance understanding of drug delivery in cancer therapy.